(Q30485897)

18 August 2017

Cost-effectiveness of insulin analogues for diabetes mellitus (English)

1 reference

cost-effectiveness analysis

18 August 2017

1 reference

Chris G Cameron

1

1 reference

PMCID

2638053

18 August 2017

Heather A Bennett

series ordinal

2

1 reference

PMCID

2638053

18 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

Canadian Medical Association Journal

18 August 2017

1 reference

18 August 2017

180

1 reference

18 August 2017

4

1 reference

18 August 2017

400-407

1 reference

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Rosiglitazone for type 2 diabetes mellitus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Preference-Based EQ-5D index scores for chronic conditions in the United States

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Generalisability in economic evaluation studies in healthcare: a review and case studies.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

National Institute for Clinical Excellence and its value judgments

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Cost of managing complications resulting from type 2 diabetes mellitus in Canada

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Willingness to pay for a quality-adjusted life year: in search of a standard

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Handling uncertainty in economic evaluations of healthcare interventions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

An introduction to Markov modelling for economic evaluation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Factors that predicted change in health-related quality of life were identified in a cohort of diabetes mellitus type 1 patients.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638053

Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness

26 November 2018

1 reference

12 December 2020

Valuing health-related quality of life in diabetes

1 reference

12 December 2020

Validation of the CORE Diabetes Model against epidemiological and clinical studies

1 reference

12 December 2020

1 reference

12 December 2020

A national catalog of preference-based scores for chronic conditions in the United States

1 reference

12 December 2020

Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes

1 reference

12 December 2020

PHARMAC responds on long-acting insulin analogues

1 reference

12 December 2020

The market in diabetes

1 reference

12 December 2020

As good as it gets but good enough for which applications?

1 reference

12 December 2020

Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada

1 reference

12 December 2020

The rosiglitazone story--lessons from an FDA Advisory Committee meeting

1 reference

12 December 2020

Utilities and disutilities for type 2 diabetes treatment-related attributes

1 reference

12 December 2020

Identifiers

DOI

10.1503/CMAJ.081180

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

2638053